Canada Gairdner Wightman Award

2016 Canada Gairdner Wightman Award

Nominations for the 2016 Canada Gairdner Wightman Award are now closed (deadline was October 1, 2015). The annual award of $100,000 is given to a scientist who has demonstrated outstanding national leadership in medicine and medical science in Canada. It is given for:

1. Leadership in a specific field of biomedical sciences (basic, clinical, population health) in Canada and/or original and sustained contributions to that field at an internationally recognized level.          

2. Institutional academic and scientific leadership in Canada leading to the establishment and development of biomedical research in Canada and internationally.

The evaluation of the contributions of the nominees depends heavily on the quality of information supplied. Therefore, nominations should be accurate, detailed, current, complete, and with supporting letters reflecting the nominee's accomplishments.

The recipients will be formally announced March 23, 2016, and will be presented with their prizes at the awards dinner on October 27, 2016. If you are interested in nominating someone for the 2017 Award, nominations are due on October 1, 2016. 

 

Nominations

  • Provide a short introduction and summary in about 150 words of the nominee's leadership contribution to medicine in Canada.
  • Present a brief biography including academic, administrative and research positions, awards or recognition. 
  • Outline, in an analytical manner, how and why the leadership of the nominee has advanced medicine in Canada and/or internationally and clearly delineate how it is set apart from the work of others.
  • Provide the nominee's full current curriculum vitae and bibliography and a contact sheet listing full position, titles, letters, business address, telephone number, fax, email address and support-person contact.
  • Arrange for at least two (2) letters of support from national and international scientists familiar with the nominee's work. These are particularly valuable when analytically evaluated.
  • Self-nominations are not accepted.
  • Gairdner does not give posthumous awards.

 

Selection Process

The nominations are reviewed by the Wightman Advisory Committee, a group of 12-15 administrative leaders who are familiar with Canadian medicine. It is chaired by Dr. John Dirks, President & Scientific Director of Gairdner.

The selection made by the committee is approved by the Board of Directors of Gairdner.

All selections are final and are not subject to review or challenge.

 

Conditions

The recipient is expected to participate in the National Program, and the award must be accepted in person by the recipient at the Canada Gairdner Awards dinner on October 27, 2016.

The Prize is valued at $100,000 CDN, and is for the personal use of the recipient. In addition an award citation and a commemorative item will be presented.

Expenses for travel and accommodation – for recipients and their partners – to accept the awards are paid by Gairdner. 

Expenses for travel and accommodation for recipients and their partners to accept the awards are paid by Gairdner.

All selections are final and are not subject to review or challenge.

All nominations will be held for up to 3 years but nominations should be updated annually.

 

Please submit in electronic format (MS Word or PDF) to nominations@gairdner.org

Nominations for 2017 should be received no later than October 1, 2016 and please note that 2016 nominations are now closed. (Please note that this is a strict deadline date.) Nominations received after this date will be considered the following year.

 

Nominations for 2017, must be received by October 1, 2016.
This is a strict deadline. Nominations received after this date will be considered the following year.


Languages